CPT code 56605 represents the surgical excision of a single suspicious lesion on the vulva or perineum with submission of the specimen for laboratory analysis. This code captures a focused operative biopsy/excision of external female genital tissue and is relevant for clinicians managing suspicious vulvar lesions, pathologists processing the specimen, and payers assessing surgical benefit coverage. Nationally, accurate coding supports appropriate claims processing, quality measurement, and tracking of oncologic or pre-malignant diagnoses that may arise from vulvar lesions.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service represented by the code, typical sites of service, and the common modifiers associated with surgical procedures. The publication outlines benchmarking context and payer coverage patterns where available, summarizes clinical indications and documentation considerations relevant to accurate coding, and flags policy updates that affect billing and claims adjudication. This resource is aimed at billing professionals, surgical and gynecologic clinicians, and policy analysts seeking a clear, nationally oriented summary of CPT code 56605 and its administrative and clinical implications.